Monday's briefing covers a major New England Journal of Medicine trial comparing aspirin, warfarin, and rivaroxaban after joint replacement, a SPRINT analysis on individualized blood pressure targets in older adults, progress on a global dementia prevention biorepository, a surprising cluster headache finding, a rare case of psychogenic blindness, and a new cancer immunotherapy target. A quick rundown covers six more studies in brief.